Taken together, these data showed that Id1-induced IGF2 from primary tumours can affect the tumour micro- and macroenvironment by systemically activating and mobilizing VEGFR1+ BMDCs to facilitate tumour growth and metastasis. Here, IGF2 is linked to neoplasm.